Literature DB >> 28463145

Treatment Recommendations for Retroperitoneal Liposarcoma.

Samuel Singer1, Kaled Alektiar2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28463145     DOI： 10.1016/j.ijrobp.2017.01.234

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  2 in total

1.  Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3.

Authors:  Yong Zhang; Hanxing Tong; Junyi He; Yebo Shao; Xi Guo; Rongyuan Zhuang; Jue Yang; Ju Liu; Yuqin Ding; Wenshuai Liu; Weiqi Lu; Yuhong Zhou
Journal:  Cell Death Dis       Date:  2019-06-03       Impact factor: 8.469

2.  A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study.

Authors:  Cheng-Li Miao; Ling-Ling Zhang; William W Tseng; Fa-Bo Qiu; Wei-Qi Lu; You-Guo Dai; Xiao-Song Rao; Wen-Jie Li; Gao-Kui Zhang; Jun Chen; Wen-Qing Liu; Xiao-Bing Chen; Meng-Meng Xiao; Li-Chao Cha; Jiong-Yuan Wang; Yu-Bo Ren; Hao-Yun Yang; Cheng-Hua Luo
Journal:  Ann Transl Med       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.